The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Portrait of Tommy Cedervall; Photo: Kennet Ruona

Tommy Cedervall

Associate Professor, Coordinator Nanosafety

Portrait of Tommy Cedervall; Photo: Kennet Ruona

The nanoparticle protein corona formed in human blood or human blood fractions

Author

  • Martin Lundqvist
  • Cecilia Augustsson
  • Malin Lilja
  • Kristoffer Lundkvist
  • Björn Dahlbäck
  • Sara Linse
  • Tommy Cedervall

Summary, in English

The protein corona formed around nanoparticles in protein-rich fluids plays an important role for nanoparticle biocompatibility, as found in several studies during the last decade. Biological fluids have complex compositions and the molecular components interact and function together in intricate networks. Therefore, the process to isolate blood or the preparation of blood derivatives may lead to differences in the composition of the identified protein corona around nanoparticles. Here, we show distinct differences in the protein corona formed in whole blood, whole blood with EDTA, plasma, or serum. Furthermore, the ratio between particle surface area to protein concentration influences the detected corona. We also show that the nanoparticle size per se influences the formed protein corona due to curvature effects. These results emphasize the need of investigating the formation and biological importance of the protein corona in the same environment as the nanoparticles are intended for or released into.

Department/s

  • Biochemistry and Structural Biology
  • Clinical Chemistry, Malmö
  • NanoLund: Center for Nanoscience

Publishing year

2017-04-01

Language

English

Publication/Series

PLoS ONE

Volume

12

Issue

4

Document type

Journal article

Publisher

Public Library of Science (PLoS)

Topic

  • Medicinal Chemistry

Status

Published

Research group

  • Clinical Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 1932-6203